Crescent Pharma recalls Ramipril 10mg capsules due to manufacturing error
Crescent Pharma Limited is recalling a batch of Ramipril 10mg Capsules due to a potential manufacturing error.
Signal
Crescent Pharma recalls Ramipril 10mg capsules due to manufacturing error
Company
Crescent Pharma Limited
Category
Strategy
Therapeutic Area
Cardiovascular / ACE Inhibitor
Action
Monitor
Signal assessment
Signal strength
high
Confidence level
high
Strategic implication
Portfolio teams should assess the potential impact on sales and consider strategies to mitigate reputational damage.
Why it matters
The recall of Ramipril 10mg capsules by Crescent Pharma due to a manufacturing error poses significant risks to the company's reputation and market share in the cardiovascular segment. Portfolio teams must closely monitor the situation to assess potential impacts on sales and develop strategies to mitigate reputational damage.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor for updates on the recall process and any regulatory actions taken by health authorities.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.